Moreover, overexpressed PLP1 exhibited major oxidative phosphorylation deficits (Wight, 2017) and the down-regulation of oxidative phosphorylation aggravates therapeutically adverse tumor hypoxia (Ashton et al., 2018). This evidence concerns the gene PLP1 and neoplasm.